Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jun 6;21(9):1653–1662. doi: 10.1016/j.bbmt.2015.05.025

Figure 1.

Figure 1

Recipient CMV Sero+/React- and React+ results in expansion of KIR2DL2/3+ and NKG2C+CD57+ NK cells post transplant. (A) NKG2C+CD57+ cells were evaluated from Sero-/React-(black bars, n=91), Sero+/React- (light gray bars, n=53) and CMV React+ (white bars, n=59), (B) NKG2C+CD57-, (C) NKG2A+, (D) KIR2DL1+, (E) KIR2DL2/3+ and (F) KIR3DL1+ expression was evaluated on CD56+CD3- NK cells post transplant from CMV Sero-/React- (black bars, n=116), Sero+/React- (light gray bars, n=54) and CMV React+ (white bars, n=57). Recipient samples were analyzed at 100 days, 6 months and 1 year post transplant. Bars represent the mean percentage of lymphocytes expressing each phenotype ± SEM. T test (equal-variance or unequal-variance t test, based on variance test result) was used for the pairwise comparisons between groups at each time point. *p<0.05, **p<0.01, ***p<0.001.